Marlies van Hoef

The letters during detention by immigrations and customs enforcement

Fight for freedom

PDF

Fight for Freedom

Fight for freedom

Proceedings in Deprivation of Rights

Detention Double Jeopardy

Criminal System Stalking Practices

Petitions for Writ of Error

Four Trials for one Charge

Intensive and/or dose dense induction chemotherapy, an autologous transplant strategy consisting of two semi-high-dose autologous transplants or equivalent in acute leukemia followed by an non-myeloablative reduced intensity conditioning allogeneic transplants in patients with donor compared to patients without donor (AML, ALL, CML, HD, NHL, MM).

Intensive and/or dose dense induction chemotherapy, an autologous transplant strategy consisting of two semi-high-dose autologous transplants or equivalent in acute leukemia followed by an non-myeloablative reduced intensity conditioning allogeneic transplants in patients with donor compared to patients without donor (AML, ALL, CML, HD, NHL, neuroblastoma)

6

Dose intensive induction, consolidation by a cytarabin containing regimen and a non-myeloablative reduced intensity conditioning allogeneic transplants in patients with and without donor for acute myeloid leukemia.

Protocol for CML until molecular complete remission has been obtained followed by a non-myeloablative reduced intensity conditioning allogeneic transplant within 12 months from diagnosis.

Dose dense induction, followed by two semi-high-dose conditioning autologous transplants and a non-myeloablative reduced intensity conditioning allogeneic transplants in patients with and without donor for lymphoma.

Dose dense induction, followed by two semi-high-dose conditioning autologous transplants and a non-myeloablative reduced intensity conditioning allogeneic transplants in patients with and without donor for multiple myeloma.

Dose dense induction, followed by two semi-high-dose conditioning autologous transplants and a non-myeloablative reduced intensity conditioning allogeneic transplants in patients with and without donor for neuroblastoma.

Dose dense induction chemotherapy, two semi-high-dose conditioning autologous peripheral blood progenitor cell transplant and a non-myeloablative reduced intensity conditioning allogeneic stem cell transplants in patients with and without donor for lymph node 4+ and to the bone marrow metastasized breast cancer

Multicenter phase I-II study of intensified induction and consolidation chemotherapy with autologous PBPC infusion followed by non-myeloablative HLA-identical sibling transplant for early metastatic breast cancer.

Multicenter phase I-II study of intensified induction and consolidation chemotherapy with autologous PBPC infusion followed by non-myeloablative HLA-identical sibling transplant for early metastatic breast cancer

Multicenter phase I-II project for studying treatment by intensive dose dense induction chemotherapy, an autologous transplant strategy consisting of two semi-high-dose autologous transplants or an equivalent in acute leukemia followed by an allogeneic non-myeloablative transpla7